- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Lei Li
Total 5832 results
-
Lei LiUnknownGynecologic Cancer | Febrile Neutropenia | Chemotherapy-induced Neutropenia | Myelosuppression AdultChina
-
Lei LiUnknownLynch Syndrome | Endometrial Cancer | Microsatellite Instability | Circulating Tumor CellChina
-
Lei LiUnknownEndometriosis | Adenomyosis | Genomics | Metabolomics | Ectopic Endometrium | Eutopic Endometrium | TranscriptomicsChina
-
Lei LiUnknownOvarian Cancer | High Grade Serous Carcinoma | Prognosis | Early Diagnosis | ExosomesChina
-
Lei LiRecruitingEpithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival Prognosis | ROMA IndexChina
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Lei LiRecruitingCervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical CancerChina
-
Lei LiRecruitingRecurrence | Survival Outcomes | Adjuvant Therapy | Hormone Therapy | Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis) | Fertility-sparing Surgery | Fertility OutcomesChina
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1China
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound PaclitaxelChina
-
Lei LiRecruitingMicrosatellite Instability | Recurrent Cervical Cancer | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Lei LiRecruitingEndometrial Neoplasms | SurvivalChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum ResistanceChina
-
Lei LiUnknownCervical Intraepithelial Neoplasia | Cervical Cancer Screening | Histology | p16 Protein | Cytology | High-risk Human Papillomavirus | Diagnostic AccuracyChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Liquid Biopsy | DNA Methylation | Benign Ovarian Tumor | Training Set | Validation Set | Cell-free DNAChina
-
Lei LiUnknownCamrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine CarcinomasChemotherapy | Recurrent Cervical Carcinoma | Adverse Drug Event | Cervical Neuroendocrine Carcinoma | Objective Response Rate | Advanced Cervical Carcinoma | Anti-pd-1 AntibodyChina
-
Lei LiUnknownEpithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | ChineseChina
-
Lei LiUnknownEndometrial Cancer | Adenomyosis | Genomics | Eutopic Endometrium | Transcriptomics | Ectopic Endometrial TissueChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Metabolomics | Transcriptomics | Whole Exome Sequencing | Tumor Invasiveness | TumorigenesisChina
-
Lei LiUnknown
-
Lei LiUnknownUterine Cervical Neoplasms | SurvivalChina
-
National Taiwan University HospitalYu-Li Hospital; Yu-Li Veterans HospitalCompletedMetabolic Syndrome XTaiwan
-
Fei LiUnknownLaparoscopic Colorectal SurgeryChina
-
Lei LiAcademy Military Medical Science, ChinaUnknownOvarian Neoplasms | Microbiota | Ribosome AlterationChina
-
LI XIN-XIANGNot yet recruitingAdvanced Rectal Cancer | Distal MetastasisChina
-
Lingjiang LiRecruitingDepressive Disorder | Melancholia | Endogenous DepressionChina
-
LI XIN-XIANGCompleted
-
li xiongUnknown
-
Li-jun DingUnknown
-
Aimee LiCompleted
-
Yin LiCompleted
-
Qi-Yong LiCompletedBiliary Diseases | Pancreas DiseasesChina
-
Qian-wei LiUnknown
-
Cheng LiRecruitingSarcopenia | Diabetes Mellitus Type 2China
-
Zheng LiNot yet recruitingCognitive Dysfunction | Frailty | Community-dwelling Older Adults
-
Hua LiRecruitingPersonalized Cancer TreatmentChina
-
Xuesong LiRecruitingUrothelial Carcinoma Ureter | Locally AdvancedChina
-
Peking University Third HospitalYunfeng LiNot yet recruiting
-
Hua LiRecruiting
-
Junling LiRecruitingAdvanced Non Squamous NSCLCChina
-
Li XuyanRecruitingChronic Thromboembolic Pulmonary HypertensionChina
-
Li MinRecruiting
-
Yuhong LiRecruitingMetastatic Colorectal CancerChina
-
Qi-Yong LiActive, not recruitingGallstones | Choledocholithiasis | Cholangiopancreatography, Endoscopic RetrogradeChina
-
Yuhong LiCompletedAdvanced Esophageal CarcinomaChina
-
Yuhong LiCompletedEsophageal Squamous Cell CarcinomaChina
-
Yuhong LiCompletedMetastatic Pancreatic CancerChina
-
Yuhong LiCompletedEsophageal Squamous Cell CarcinomaChina